New tech tackles gaps in antibody discovery
A new research tool now lets scientists observe how single cells actually behave during antibody discovery. Lightcast Envisia platform captures live cell reactions using droplet-based microfluidics, offering an alternative to traditional gene-based screening. This shift may reduce failed drug leads and improve outcomes in early-stage biologic development.